908 Devices (MASS) Asset Writedowns and Impairment (2020 - 2026)
908 Devices' (MASS) quarterly Asset Writedowns and Impairment came in at -$13000.0 in Q1 2026, down 111.93% year-on-year from $109000.0 in Q1 2025, and down 109.63% on a QoQ basis from $135000.0 in Q4 2025.
908 Devices (MASS) Asset Writedowns and Impairment (2020 - 2026) Analysis & Trends
908 Devices (MASS) has 7 years of Asset Writedowns and Impairment data on file, last reported at -$13000.0 in Q1 2026.
- On a quarterly basis, Asset Writedowns and Impairment fell 111.93% year-over-year to -$13000.0 in Q1 2026; TTM through Mar 2026 was $391000.0, a 36.01% decrease from a year earlier, with the FY2025 full-year figure at $513000.0, down 21.44% from the prior year.
- Asset Writedowns and Impairment for Q1 2026 stood at -$13000.0, down from $135000.0 in the prior quarter.
- Over the last five years, Asset Writedowns and Impairment for MASS reached as high as $379000.0 in Q4 2023 and fell as low as -$13000.0 in Q1 2026.
- Historically, Asset Writedowns and Impairment has averaged $141375.0 across 5 years, with a median of $117500.0 in 2024.
- Across the five-year window, Asset Writedowns and Impairment soared 3414.29% in 2023 and plunged 111.93% in 2026, its largest moves.
- Year by year, Asset Writedowns and Impairment stood at $330000.0 in 2022, then grew by 14.85% to $379000.0 in 2023, then plunged by 66.75% to $126000.0 in 2024, then gained by 7.14% to $135000.0 in 2025, then sank by 109.63% to -$13000.0 in 2026.
- Per Business Quant data, the three most recent Asset Writedowns and Impairment figures were -$13000.0 in Q1 2026, $135000.0 in Q4 2025, and $169000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.82 Bn | 176.53 Bn | 6.27 Bn |
| 2 | Stryker | 129.01 Bn | 126.13 Bn | 3.81 Bn |
| 3 | Medtronic | 108.52 Bn | 99.30 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.59 Bn | 67.14 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.35 Bn | 44.68 Bn | 1.29 Bn |
| 6 | Dexcom | 28.35 Bn | 27.23 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.11 Bn | 25.82 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.89 Bn | 26.32 Bn | - |
| 9 | Koninklijke Philips | 24.28 Bn | 21.15 Bn | 2.07 Bn |
| 10 | 908 Devices | 259.57 Mn | 147.83 Mn | 6.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -13,000.00 |
| Mar 31, 2026 | -13,000.00 |
| Dec 31, 2025 | 135,000.00 |
| Dec 31, 2025 | 135,000.00 |
| Sep 30, 2025 | 169,000.00 |
| Sep 30, 2025 | 169,000.00 |
| Jun 30, 2025 | 100,000.00 |
| Jun 30, 2025 | 100,000.00 |
| Mar 31, 2025 | 109,000.00 |
| Mar 31, 2025 | 109,000.00 |
| Dec 31, 2024 | 126,000.00 |
| Dec 31, 2024 | 126,000.00 |
| Sep 30, 2024 | 298,000.00 |
| Sep 30, 2024 | 298,000.00 |
| Jun 30, 2024 | 78,000.00 |
| Jun 30, 2024 | 78,000.00 |
| Mar 31, 2024 | 151,000.00 |
| Mar 31, 2024 | 151,000.00 |
| Dec 31, 2023 | 379,000.00 |
| Dec 31, 2023 | 379,000.00 |